期刊文献+

Betatrophin与糖尿病的研究进展 被引量:1

Research progress of betatrophin and diabetes
下载PDF
导出
摘要 补充胰岛再生β细胞的数量被认为是一个潜在治疗糖尿病的一个靶点。最近研究证实胰岛再生激素(Betatrophin)具有高效、显著提高β细胞增殖的能力,并且可显著提高糖耐受的能力。Betatrophin的发现为糖尿病的治疗提供了新型的治疗机会。以往的研究主要集中于它的特征和功能以及胰腺β细胞的增殖情况,本文则对Betatrophin与糖尿病的最新进展进行总结。 Replenishing the insulin-producing/β-cells is considered as a potential cure method for diabetes. A recent study identified a secreted protein, betatrophin, could potently and significantly improve the ability of beta cell proliferation, and can significantly improve the sugar tolerance ability. The discovery of betatrophin provided a new type of therapy for the treatment of diabetes. The previous studies mainly focused on its features and functions as well as the proliferation of the pancreatic beta ceils. In this article, the research progress of betatrophin and diabetes were summarized
出处 《海南医学》 CAS 2015年第5期690-692,共3页 Hainan Medical Journal
基金 国家自然科学基金(编号:81172788) 湖北省高等学校优秀中青年科技创新团队计划(编号:T201203)
关键词 Betatrophin 胰岛素 糖尿病 Betatrophin Insulin Diabetes
  • 相关文献

参考文献16

  • 1Ren G, Kim JY, Smas CM. Identification of RIFL, a novel adipo- cyte-enfiched insulin target gene with a role in lipid metabolism [J]. Am Journal of Physiol Endocrinol Metab, 2012, 303(3): E334-351.
  • 2Zhang R. Lipasin, a novel nutritionally-regulated liver-enriched fae-tor that regulates serum triglyceride levels [J]. Biochem Biophys Res Commun, 2012, 424(4): 786-792.
  • 3Quagliarini F, Wang Y, Kozlitma J, et al. Atypical angiopoietin-like protein that regulates ANGPTL3 [J]. Proc Nat Acad Sei USA, 2012, 109(48): 19751-19756.
  • 4Yi P, Park JS, Melton DA. Betalxophin: a hormone that controls pancreatic beta cell proliferation [J]. Cell, 2013, 153(4): 747-758.
  • 5Talchai C, Xuan S, Lin HV, et al. Pancreatic beta cell de, differentia- tion as a mechanism of diabetic beta cell failure [J]. Cell, 2012, 150 (6): 1223-1234.
  • 6Teodoro JS, Gomes AP, Varela AT, et al. Uncovering the beginning of diabetes: the cellular redox status and oxidative stress as starting players in hyperglycemic damage [J]. Mol Cell Biochem, 2013, 376 (1-2): 103-110.
  • 7Biddinger SB, Hemandez-Ono A, Rask-Madsen C, et al. Hepatic in- sulin resistance is sufficient to produce dyslipidemia and susceptibil- ity to atherosclerosis [J]. Cell Metab, 2008, 7(2): 125-134.
  • 8Zhang R, Abou-Samra AB. Emerging roles of Lipasin as a critical lipid regulator [J]. Riochem Biophys Res Commun, 2013, 432(3): 401-405.
  • 9Fu Z, Berhane F, Fire A, et al. Elevated circulating lipasin/Betatro- plain in human type 2 diabetes and obesity [J]. Sci Rep, 2014, 4: 5013.
  • 10Ouaamari AE, Kawamofi D, Dirice E, et al. Liver-derived systemic factors drive beta ceil hyperplasia in insulin-resistant states [J]. Cell Rep, 2013, 3(2): 401-410.

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部